High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer.

Chelsea Mayoh, Jie Mao,Jinhan Xie, Gabor Tax,Shu-Oi Chow,Roxanne Cadiz, Karina Pazaky,Paulette Barahona,Pamela Ajuyah,Peter Trebilcock, Angela Malquori, Kate Gunther, Anica Avila, Doo Young Yun,Stephanie Alfred,Anjana Gopalakrishnan,Alvin Kamili,Marie Wong,Mark J Cowley, Sophie Jessop,Loretta M S Lau,Toby N Trahair,David S Ziegler,Jamie I Fletcher,Andrew J Gifford,Maria Tsoli,Glenn M Marshall,Michelle Haber,Vanessa Tyrrell,Timothy W Failes,Greg M Arndt,Richard B Lock,Paul G Ekert,M Emmy M Dolman

Cancer research（2023）

引用 0|浏览36

暂无评分

摘要

Integrating HTS with molecular profiling is a powerful tool for expanding precision medicine to support drug treatment recommendations and broaden the therapeutic options available to high-risk pediatric cancers.

查看译文

关键词

primary tumor cells identifies,cancer,high-throughput,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要